Current international trends in the treatment of multiple sclerosis in children—Impact of the COVID-19 pandemic

BACKGROUND: Only recently has the first disease-modifying therapy been approved for children with multiple sclerosis (MS) and practice patterns including substantial off-label use have evolved. Understanding attitudes towards treatment of paediatric MS and whether this has changed due to the ongoing...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandesjö, Fredrik, Wassmer, Evangeline, Deiva, Kumaran, Amato, Maria Pia, Chitnis, Tanuja, Hemingway, Cheryl, Krupp, Lauren, Pohl, Daniela, Rostasy, Kevin, Waubant, Emanuelle, Banwell, Brenda, Wickström, Ronny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474759/
https://www.ncbi.nlm.nih.gov/pubmed/34624643
http://dx.doi.org/10.1016/j.msard.2021.103277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474759/
https://www.ncbi.nlm.nih.gov/pubmed/34624643
http://dx.doi.org/10.1016/j.msard.2021.103277

Ejemplares similares